- Ongoing, recruitingTherapeutic exploratory (Phase II)
A Phase 2, Multicenter Study to Evaluate the Efficacy and Safety Using Autologous Tumor Infiltrating Lymphocytes (LN-145) in Patients with Recurrent, Metastatic, or Persistent Cervical Carcinoma
This study is testing an immunotherapy called LN-145 for women with cervical cancer that has come back, spread, or hasn't responded to other treatments. It's looking at how well the treatment shrinks tumours and if it's safe to use.
For: Recurrent · metastatic · or persistent Cervical CarcinomaGermany · Netherlands · France - RecruitingPHASE2
Autologous LN-145 in Patients With Metastatic Non-Small-Cell Lung Cancer
This study looks at a new treatment called LN-145 for advanced lung cancer (non-small cell type) that has spread. It involves using your own immune cells to fight the cancer. Researchers want to see how safe and effective this treatment is.
For: Metastatic Non Small Cell Lung CancerUnited States · Australia · Canada - Ongoing, recruitingTherapeutic exploratory (Phase II)
A Phase 2, Multicenter Study of Autologous Tumor Infiltrating Lymphocytes (LN-144/LN-145/LN-145-S1) in Patients with Solid Tumors
This study looks at a new treatment for solid tumours, which are common types of cancer. It uses a patient's own immune cells, called TILs, to fight the cancer. Researchers want to see how well these cells work at shrinking tumours and keeping the cancer away.
For: NeoplasmSpain · Germany · Greece